Disease Overview：Missed abortion（MA）
Embryonic arrest, also known as embryonic demise or early pregnancy failure, refers to the cessation of embryonic development prior to 10 weeks’ gestation—typically confirmed via transvaginal ultrasound showing an empty gestational sac, absence of fetal pole or cardiac activity despite appropriate gestational age, or a crown-rump length ≥7 mm without detectable heartbeat. It is distinct from biochemical pregnancy loss and clinical miscarriage, representing a specific pathological endpoint in early gestation often linked to chromosomal abnormalities (e.g., aneuploidy), endocrine dysfunction (e.g., luteal phase defect, uncontrolled thyroid disease), immunologic factors, thrombophilias, or uterine anomalies such as septate uterus or intrauterine adhesions. Diagnosis requires careful correlation of serial β-hCG trends, ultrasound morphology, and clinical history. Management options include expectant, medical (misoprostol ± mifepristone), or surgical (vacuum aspiration) approaches, followed by comprehensive evaluation—including karyotyping of products of conception, hormonal profiling, thrombophilia screening, and hysteroscopic assessment—to guide personalized recurrent pregnancy loss protocols.
China offers distinct advantages for international patients seeking evidence-based care for embryonic arrest and its underlying causes. Leading reproductive medicine centers—many accredited by ISO and Joint Commission International—employ advanced technologies including next-generation sequencing for embryo aneuploidy screening (PGT-A), high-resolution 3D/4D hysteroscopy, and automated time-lapse embryo monitoring systems. Clinicians routinely publish in peer-reviewed journals and maintain robust outcome registries: top-tier hospitals report live birth rates exceeding 65% per fresh IVF cycle in carefully selected recurrent implantation failure cohorts. Crucially, comprehensive diagnostic workups and targeted interventions—including immunomodulation, endometrial receptivity array (ERA) testing, and corrective hysteroscopic surgery—are delivered at approximately 40–60% lower cost than comparable services in the US, UK, or Germany—without compromising clinical rigor or safety standards.
As a dedicated medical tourism agency, we facilitate seamless access to these specialized services for global patients. We coordinate appointments with certified reproductive endocrinologists, verify hospital credentials, provide itemized, transparent pricing in advance, and offer end-to-end support—from visa assistance and accommodation to multilingual clinical liaison and post-treatment follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Embryonic Arrest (Reproductive Medicine Department)
Non-Surgical / Conservative / Medication Options
*Indicated for early embryonic arrest (<12 weeks) with stable vital signs, no active bleeding/infection, and patient preference for expectant or medical management.*
- •Expectant Management
- *Fees:* - Serial β-hCG monitoring (×3): $45–$65 - Transvaginal ultrasound (×2): $85–$120 - Clinical follow-up visits (×3): $30–$45 - Total range: $160–$230
- •Medical Management (Misoprostol ± Mifepristone)
- *Fees:* - Mifepristone (200 mg ×1 dose): $25–$35 - Misoprostol (800 µg vaginal): $12–$18 - Pre-treatment CBC, coagulation panel, pelvic US: $110–$155 - Post-treatment US + β-hCG (day 7–14): $75–$105 - Total range: $222–$313
Surgical / Procedural Options
*Indicated for incomplete/inevitable abortion, heavy bleeding (>80 mL/h), infection, or patient preference after counseling.*
- •Vacuum Aspiration (Manual or Electric)
- *Preoperative fees:* - ECG, chest X-ray, CBC, PT/INR, blood type/Rh, vaginal secretion culture: $135–$185 - *Procedure fee (incl. anesthesia, facility, pathology):* $320–$480 - *Total range:* $455–$665
- •Dilation & Curettage (D&C) with Hysteroscopy
- *Preoperative fees (same as above):* $135–$185 - *Procedure fee (incl. hysteroscopic visualization, tissue sampling, anesthesia):* $590–$840 - *Total range:* $725–$1,025
Special / Complex Condition Options
- •Recurrent Embryonic Arrest (≥2 episodes):
- Thrombophilia panel (Protein C/S, Antithrombin III, Factor V Leiden, APC resistance): $260–$370 - Endometrial receptivity assay (ERA) + chronic endometritis biopsy: $480–$650
- •Immunomodulatory Therapy (e.g., IVIG, low-dose aspirin + heparin):
- IVIG (0.4 g/kg ×1 course): $1,280–$1,850
Quick Selection Guide
- •<35 years, first episode, budget-conscious: Expectant management ($160–$230) — highest safety, lowest cost.
- •35–42 years, rapid resolution needed, moderate budget: Medical management ($222–$313) — avoids surgery, effective in >85%.
- •≥43 years or recurrent loss: Vacuum aspiration ($455–$665) + mandatory thrombophilia/endometrial testing ($740–$1,020 total) — balances efficiency and diagnostic yield.
- •Comorbidities (hypertension, diabetes, obesity): D&C with hysteroscopy ($725–$1,025) — superior control, lower re-intervention risk.
- •Prior 3+ losses + autoimmune history: IVIG + LMWH ($1,425–$2,055/month) — evidence-supported for select immunologic subtypes.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Missed abortion Medical Vacation Packages
Curated transparent all-inclusive packages combining Missed abortion treatment with China top medical destinations:
